Sign In
Buy OPK
$1.46
+0.0600 (+4.29%)
At Close: Jun 03, 2026
OPKO Health, Inc. (OPK) CEO Phil Frost on Q3 2020 Results - Earnings Call Transcript
10:46pm, Thursday, 29'th Oct 2020
OPKO Health, Inc. (OPK) CEO Phil Frost on Q3 2020 Results - Earnings Call Transcript
OPKO Health: Q3 Earnings Insights
04:43pm, Thursday, 29'th Oct 2020
Shares of OPKO Health (NASDAQ:OPK) fell 6.4% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share were up 144.44% year over year to $0.04, which were in
OPKO's Rayaldee Drug Could Be A Leading COVID-19 Treatment
12:44pm, Thursday, 20'th Aug 2020
Yale's saliva-based coronavirus test funded by NBA gets emergency authorization from the FDA. Is BioReference at the front of the line to use this new test because of the assistance it has provided? W
Do Options Traders Know Something About OPKO Health (OPK) Stock We Don't?
12:54pm, Monday, 17'th Aug 2020
Investors need to pay close attention to OPKO Health (OPK) stock based on the movements in the options market lately.
The Charts of Opko Health Suggest it Can Correct Further to the Downside
03:12pm, Friday, 14'th Aug 2020
In this daily bar chart of OPK, below, we can see that prices made a smallish basing pattern from last August to this April. The On-Balance-Volume (OBV) line moved up from February to July but has cu
HMS Holdings (HMSY) Loses 2.9% Since Q2 Earnings Release
12:06pm, Thursday, 13'th Aug 2020
HMS Holdings (HMSY) witnessed revenue growth in COB segment in Q2.
ROCE Insights For OPKO Health
04:04pm, Wednesday, 12'th Aug 2020
OPKO Health (NASDAQ: OPK) showed a loss in earnings since Q1, totaling $27.18 million. Sales, on the other hand, increased by 42.41% to $301.20 million during Q2. In Q1, OPKO Health brought in $211.50
OPKO Health's GeneDx Enters into Agreement with Pediatrix Medical Group to Offer Neonatal Genomic Services
01:15pm, Wednesday, 12'th Aug 2020
GeneDx, Inc., a subsidiary of BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), the global leader in neonatal and pediatric genetic testing, announced the entrance into an agreemen
Surmodics (SRDX) Q3 Earnings and Revenues Beat Estimates
12:17pm, Monday, 10'th Aug 2020
Surmodics (SRDX) registered revenue growth in each of its core units viz. In Vitro Diagnostics and Medical Device in Q3.
Cambridge Investment Research Advisors Inc. Sells 27,700 Shares of Opko Health Inc. (NASDAQ:OPK)
11:02pm, Sunday, 09'th Aug 2020
Cambridge Investment Research Advisors Inc. lowered its holdings in Opko Health Inc. (NASDAQ:OPK) by 7.4% during the second quarter, according to the company in its most recent Form 13F filing with th
Has OPKO Health (OPK) Outpaced Other Medical Stocks This Year?
03:30pm, Friday, 07'th Aug 2020
Is (OPK) Outperforming Other Medical Stocks This Year?
Nevro (NVRO) Q2 Loss Narrower than Expected, Revenues Beat
11:20am, Friday, 07'th Aug 2020
Nevro's (NVRO) domestic and international revenues declined on a year-over-year basis in Q2.
OPKO Health's GeneDx Adds GenomeXpress to Its Industry-Leading Clinical Genomics Portfolio
12:00pm, Thursday, 06'th Aug 2020
GeneDx, Inc., a subsidiary of BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the launch of GenomeXpress, a rapid genome sequencing test. Verbal GenomeXpress resu
OPKO Health to Participate in BTIG Virtual Biotechnology Conference
07:35pm, Wednesday, 05'th Aug 2020
MIAMI, Aug. 05, 2020 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that management will participate in a fireside chat at the BTIG Virtual Biotechnology Conference on Monday, Aug
Global Secondary Hyperparathyroidism Pipeline Insights, 2020 - ResearchAndMarkets.com
12:00am, Tuesday, 04'th Aug 2020
The
